Scholars Central

Case reportPublished 22 Sep 2023

Fatal Dermatological Squeal Following Depot Medroxyprogesterone Acetate (DMPA) Administration: A Catastrophic Hypersensitivity Case Report

Authors: Aisha Siddiqui, Farina Fatima Siddiqui, Muhmmad Hamza Gul, Yugam Rajeshkumar Oza, Miruthu Varshini Jayaprakash

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The use of depot progesterone as a contraceptive every three months by a considerable number of women has raised concerns regarding the potential for hormones and chemicals to trigger fatal immune responses resulting in skin reactions. The focus of our case report is a 25-year-old woman who suffered a fatal dermatological condition after using this contraceptive. It is noteworthy that this specific condition has not been documented in medical literature before.

Subjects

Dermatology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Dermatology Research Journal
  • SubjectDermatology
  • BylineArticles whose byline prints “Aisha Siddiqui”
  • BylineArticles whose byline prints “Farina Fatima Siddiqui”
  • BylineArticles whose byline prints “Muhmmad Hamza Gul”
  • BylineArticles whose byline prints “Yugam Rajeshkumar Oza”
  • BylineArticles whose byline prints “Miruthu Varshini Jayaprakash”